The PROTEA trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV-1 RNA below 50 copies/mL

INTRODUCTION: In previous studies, protease inhibitor (PI) monotherapy has shown trends for higher low-level elevations in HIV-1 RNA compared to triple therapy, but no increase in the risk of drug resistance. METHODS: A total of 273 patients with HIV-1 RNA <50 copies/mL for over 24 weeks on curre...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Int AIDS Soc
Main Authors: Antinori, Andrea, Arribas, Jose, Fehr, Jan, Girard, Pierre-Marie, Horban, Andrzej, Hill, Andrew, van Delft, Yvon, Moecklinghoff, Christiane
Formato: Artigo
Idioma:Inglês
Publicado: International AIDS Society 2014
Assuntos:
Oral Presentation – Abstract O423A
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4224888/
https://ncbi.nlm.nih.gov/pubmed/25394034
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7448/IAS.17.4.19525
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares